Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This study aimed to evaluate the pharmacokinetic characteristics and bioequivalence of two olaparib tablets in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Epistemonikos ID: 89bbc1722f3b4e27c84004bece150cbd85ce6a94
First added on: Feb 19, 2024